• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜胃旁路术后预防静脉血栓栓塞的常规抗凝治疗。

Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass.

作者信息

Frantzides Constantine T, Welle Scott N, Ruff Timothy M, Frantzides Alexander T

机构信息

Chicago Institute of Minimally Invasive Surgery, Skokie, IL 60077, USA.

出版信息

JSLS. 2012 Jan-Mar;16(1):33-7. doi: 10.4293/108680812X13291597716906.

DOI:10.4293/108680812X13291597716906
PMID:22906327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3407454/
Abstract

OBJECTIVE

To compare the rates of venous thromboembolism (VTE) by using routine postoperative enoxaparin versus early ambulation, SCDs, hydration, and selective prophylactic pharmacologic anticoagulation.

METHODS

1,692 patients undergoing laparoscopic gastric bypass from October 2001 to October 2008 were included and divided into 2 groups based on when they were operated upon. Group A (435 patients) received routine enoxaparin 12 hours after surgery. Group B (1,257 patients) received selective pharmacologic anticoagulation, in high-risk patients only.

RESULTS

Mean operating time was 144±26 minutes (Group A) and 126±15 minutes (Group B). Mean length of stay was 2.3±1.5 days for Group A and 1.4±1.2 for Group B. Intraluminal bleeding occurred in 21 patients (4.8%) in Group A and 5 (0.9%) in Group B; none required intervention. Five pulmonary embolisms occurred in Group A (1.1%) and none in Group B. Seven patients in Group A (1.7%) and 6 (0.47%) in Group B had clinically evident DVT. Two non-VTE related deaths occurred in Group A.

CONCLUSIONS

Adequate VTE prophylaxis is achieved using SCDs, early ambulation, emphasis on hydration, and shorter operating times. Bariatric surgery can be safely performed without pharmacologic VTE prophylaxis in all but the high-risk population. Fewer bleeding complications occur without the use of anticoagulants.

摘要

目的

比较术后常规使用依诺肝素与早期活动、使用下肢循环驱动仪(SCDs)、补液及选择性预防性药物抗凝治疗静脉血栓栓塞症(VTE)的发生率。

方法

纳入2001年10月至2008年10月期间行腹腔镜胃旁路手术的1692例患者,并根据手术时间将其分为两组。A组(435例患者)术后12小时接受常规依诺肝素治疗。B组(1257例患者)仅对高危患者进行选择性药物抗凝治疗。

结果

A组平均手术时间为144±26分钟,B组为126±15分钟。A组平均住院时间为2.3±1.5天,B组为1.4±1.2天。A组21例患者(4.8%)发生腔内出血,B组5例患者(0.9%)发生腔内出血;均无需干预。A组发生5例肺栓塞(1.1%),B组无肺栓塞发生。A组7例患者(1.7%)发生临床明显的深静脉血栓形成(DVT),B组6例患者(0.47%)发生临床明显的DVT。A组发生2例与VTE无关的死亡。

结论

通过使用SCDs、早期活动、强调补液及缩短手术时间可实现充分的VTE预防。除高危人群外,减重手术可不使用药物进行VTE预防而安全实施。不使用抗凝剂时出血并发症较少。

相似文献

1
Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass.腹腔镜胃旁路术后预防静脉血栓栓塞的常规抗凝治疗。
JSLS. 2012 Jan-Mar;16(1):33-7. doi: 10.4293/108680812X13291597716906.
2
Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures.对于所有腹腔镜Roux-en-Y胃旁路手术,并非都必须进行静脉血栓栓塞并发症的药物预防。
J Am Coll Surg. 2009 May;208(5):917-21; discussion 921-3. doi: 10.1016/j.jamcollsurg.2009.01.034.
3
Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial.间歇性气动压迫与依诺肝素预防性治疗在预防胃和结直肠恶性肿瘤腹腔镜手术后静脉血栓栓塞中的作用:多中心随机临床试验。
BJS Open. 2020 Oct;4(5):804-810. doi: 10.1002/bjs5.50323. Epub 2020 Jul 23.
4
Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.依诺肝素在胃旁路手术患者中的血栓预防:延长疗程、剂量分层及抗Xa因子活性
Surg Obes Relat Dis. 2008 Sep-Oct;4(5):625-31. doi: 10.1016/j.soard.2007.11.010. Epub 2008 Feb 8.
5
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?全膝关节置换术后静脉血栓栓塞的预防:阿司匹林、华法林、依诺肝素还是Xa因子抑制剂?
Clin Orthop Relat Res. 2017 Sep;475(9):2205-2213. doi: 10.1007/s11999-017-5394-6. Epub 2017 May 31.
6
Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures.评估 VTE 预防措施以及替代方案对减重手术后出血和血栓并发症的影响。
Surg Endosc. 2018 Dec;32(12):4805-4812. doi: 10.1007/s00464-018-6231-z. Epub 2018 May 15.
7
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
8
Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.抗Xa因子指导下的依诺肝素血栓预防可降低高危创伤患者深静脉血栓形成的发生率。
J Trauma Acute Care Surg. 2016 Dec;81(6):1101-1108. doi: 10.1097/TA.0000000000001193.
9
The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding.依诺肝素预防给药方案(一日一次或一日两次)对静脉血栓栓塞和临床相关出血风险的影响。
Plast Reconstr Surg. 2018 Jul;142(1):239-249. doi: 10.1097/PRS.0000000000004517.
10
Efficacy and safety of postoperative anticoagulation prophylaxis with enoxaparin in patients undergoing pancreatic surgery: A prospective trial and literature review.依诺肝素用于胰腺手术患者术后抗凝预防的疗效及安全性:一项前瞻性试验与文献综述
Pancreatology. 2017 May-Jun;17(3):464-470. doi: 10.1016/j.pan.2017.03.010. Epub 2017 Mar 29.

引用本文的文献

1
Polish Expert Consensus on Metabolic and Bariatric Surgery: 2025 update.《波兰代谢与减重手术专家共识:2025年更新》
Wideochir Inne Tech Maloinwazyjne. 2025 Feb 9;20(2):125-143. doi: 10.20452/wiitm.2025.17950. eCollection 2025 Jul 8.
2
Single-Dose enoxaparin for portomesenteric venous thrombosis prophylaxis after sleeve gastrectomy.单剂量依诺肝素预防袖状胃切除术后门腔静脉血栓形成。
Ann Afr Med. 2024 Jan-Mar;23(1):46-52. doi: 10.4103/aam.aam_133_23.
3
Thromboembolic Complications After Bariatric Surgery: Is the High Risk Real?减重手术后的血栓栓塞并发症:高风险是真的吗?
Cureus. 2023 Jan 6;15(1):e33444. doi: 10.7759/cureus.33444. eCollection 2023 Jan.
4
Mechanical prophylaxis for venous thromboembolism prevention in obese individuals.肥胖个体预防静脉血栓栓塞的机械性预防措施
Phlebology. 2021 Dec;36(10):768-770. doi: 10.1177/02683555211031147. Epub 2021 Jul 6.
5
Effectiveness of ambulation to prevent venous thromboembolism in patients admitted to hospital: a systematic review.住院患者下床活动预防静脉血栓栓塞的有效性:一项系统评价
CMAJ Open. 2020 Dec 8;8(4):E832-E843. doi: 10.9778/cmajo.20200003. Print 2020 Oct-Dec.
6
Thromboprophylaxis after bariatric surgery.减重手术后的血栓预防
Blood Res. 2020 Mar;55(1):44-48. doi: 10.5045/br.2020.55.1.44. Epub 2020 Mar 30.
7
A New Protocol for Venous Thromboembolism Prophylaxis in Bariatric Surgery.一种新的减重手术静脉血栓栓塞症预防方案。
Obes Surg. 2019 Feb;29(2):729-734. doi: 10.1007/s11695-018-03643-0.
8
Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database.预测腹腔镜减重手术后静脉血栓栓塞症:基于 MBSAQIP 数据库的 BariClot 工具的开发。
Surg Endosc. 2019 Mar;33(3):821-831. doi: 10.1007/s00464-018-6348-0. Epub 2018 Jul 12.
9
Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures.评估 VTE 预防措施以及替代方案对减重手术后出血和血栓并发症的影响。
Surg Endosc. 2018 Dec;32(12):4805-4812. doi: 10.1007/s00464-018-6231-z. Epub 2018 May 15.
10
Deep vein thrombosis prophylaxis: Are we overdoing? An Asian survey on trends in bariatric surgery with a systematic review of literature.深静脉血栓形成的预防:我们做得过头了吗?一项关于减肥手术趋势的亚洲调查及文献系统综述。
J Minim Access Surg. 2018 Oct-Dec;14(4):285-290. doi: 10.4103/jmas.JMAS_151_17.

本文引用的文献

1
ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients.美国代谢与减重外科学会(ASMBS)关于降低减重手术患者静脉血栓栓塞风险的预防措施的最新立场声明。
Surg Obes Relat Dis. 2013 Jul-Aug;9(4):493-7. doi: 10.1016/j.soard.2013.03.006. Epub 2013 Apr 15.
2
Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures.对于所有腹腔镜Roux-en-Y胃旁路手术,并非都必须进行静脉血栓栓塞并发症的药物预防。
J Am Coll Surg. 2009 May;208(5):917-21; discussion 921-3. doi: 10.1016/j.jamcollsurg.2009.01.034.
3
Status of venous thromboembolism prophylaxis among bariatric surgeons: have we changed our practice during the past decade?减重外科医生对静脉血栓栓塞症的预防现状:在过去十年中我们的做法有改变吗?
Surg Obes Relat Dis. 2009 May-Jun;5(3):352-6. doi: 10.1016/j.soard.2008.10.016. Epub 2008 Nov 24.
4
Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.两种低分子量肝素给药方案用于腹腔镜减肥手术患者的比较。
Surg Endosc. 2008 Nov;22(11):2392-5. doi: 10.1007/s00464-008-9997-6. Epub 2008 Jul 2.
5
Incidence of lower limbs deep vein thrombosis after open and laparoscopic gastric bypass: a prospective study.开腹和腹腔镜胃旁路术后下肢深静脉血栓形成的发生率:一项前瞻性研究。
Obes Surg. 2008 Jan;18(1):52-7. doi: 10.1007/s11695-007-9268-y. Epub 2007 Dec 15.
6
Best Poster Award. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin.最佳海报奖。接受普通肝素或依诺肝素预防方案治疗的患者腹腔镜胃旁路术后血栓栓塞和出血事件的比较。
Am J Surg. 2007 Dec;194(6):709-11. doi: 10.1016/j.amjsurg.2007.08.018.
7
Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery.腹腔镜手术期间深静脉血栓形成预防指南。
Surg Endosc. 2007 Dec;21(12):2331-4. doi: 10.1007/s00464-007-9543-y. Epub 2007 Aug 22.
8
Venous thromboembolism prophylaxis in colorectal surgery.结直肠手术中的静脉血栓栓塞预防
Surg Technol Int. 2005;14:165-70.
9
Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.依诺肝素用于肥胖症手术患者的血栓预防:接受依诺肝素的肥胖症手术患者预防静脉血栓栓塞结局的研究(PROBE研究)结果
Obes Surg. 2005 Nov-Dec;15(10):1368-74. doi: 10.1381/096089205774859245.
10
Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery.胃旁路手术中病态肥胖患者静脉血栓栓塞预防的疗效
Obes Surg. 2005 Oct;15(9):1316-20. doi: 10.1381/096089205774512690.